CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale CEO sold 6,486 shares at $9.50 ($61,638)
- 4 Planned sale EVP, CBO AND CTO sold 105 shares at $9.50 ($998)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 144 Insider Sale of Securities
- 4 Grant or award EVP, CHIEF FINANCIAL OFFICER acquired 77,900 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 949 shares at $9.87 ($9,369)
- 4 Planned sale EVP, CBO AND CTO sold 668 shares at $9.87 ($6,594)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, CBO AND CTO sold 135 shares at $9.51 ($1,284)
- 10-Q Report Quarterly Report
Page 11 of 37 · 731 filings